Contract Services

Microsize provides Particle Size Reduction, Powder Classification and Analytical Services to a range of pharma stakeholders in need of a center of excellence for their product development and/or commercial manufacturing. Microsize has unmatched expertise in developing milling and micronization processes with a diverse range of API and excipient materials with unique physical property challenges.

High turn feasibility studies can take place within our development suites with as little as 1-5 grams of API. For highly potent compounds including cytotoxics (HPAPIs), a world-class high containment infrastructure, is available in our R&D labs and GMP suites to best match the client stage of development.


Our Customers Include:

  • Small biotechs to Big Pharma
  • CDMO’s (API, Dosage Form, Integrated)
  • Functional Excipient Companies

Types of Molecules:

  • Small Molecule APIs and HPAPIs
  • Functional Excipients
  • NCEs, 505b2s, Generics

Phases of Development Supported:

  • Discovery
  • Phases I-III
  • Commercial Launch
  • Generic

Our Services Pipeline

Get In Touch

2022© Microsize